Opportunities of precision medicine for triple-negative breast cancer
10.3969/j.issn.1000-8179.2016.24.048
- VernacularTitle:三阴性乳腺癌精准治疗的机遇
- Author:
Qing YE
;
Zefei JIANG
- Keywords:
triple-negative breast cancer;
molecular subtyping;
precision treatment
- From:
Chinese Journal of Clinical Oncology
2016;43(24):1074-1077
- CountryChina
- Language:Chinese
-
Abstract:
Triple-negative breast cancer (TNBC) is a heterogeneous disease. Recently, the development of a gene expression profile fa-cilitated the re-classification of TNBC into six new subtypes, which show varied sensitivities to different therapies. In the era of preci-sion medicine, precision therapy may be directed at various potentially actionable molecular mutations in different subtypes of TNBC.
